Mercer Global Advisors’s VanEck Biotech ETF BBH Stock Holding History

Mercer Global Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.3K	Buy	+400	New	+$75.2K	﹤0.01%	3987

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Mercer Global Advisors's BBH Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 400 shares worth $81.3K. The stake represents ﹤0.01% of the portfolio and ranks #3987 among its holdings.

104 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Mercer Global Advisors held 400 shares of VanEck Biotech ETF worth $81.3K as of Q2 2026.
VanEck Biotech ETF was a new Mercer Global Advisors position in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3987 holding.
104 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.